Princeton Global Asset Management LLC Vertex Pharmaceuticals Inc Transaction History
Princeton Global Asset Management LLC
- $488 Million
- Q3 2024
A detailed history of Princeton Global Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 15,206 shares of VRTX stock, worth $7.64 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
15,206
Previous 15,084
0.81%
Holding current value
$7.64 Million
Previous $7.07 Million
0.03%
% of portfolio
1.45%
Previous 1.64%
Shares
25 transactions
Others Institutions Holding VRTX
# of Institutions
1,716Shares Held
225MCall Options Held
1.19MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$13.4 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.89 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.29 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $129B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...